SANUWAVE Health Inc (SNWV)

SNWV moved to the Nasdaq from the OTC:

https://otce.finra.org/otce/dailyList?viewType=Deletions

just wait til the uplisting is announced

SNWV: one for 375 reverse split:

https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes

i am with you, Todd. with the recent run they are trading at 1x revenues.

Awesome. I remember talking to you a long time ago about WLDN, another undervalued stock.

Sanuwave for the most part looks like an amazing undervalued investment, besides their enormous debt. If they can R/S, capital raise or renegotiate debt on better terms, the stock will take off. Other things I like about the company - their consumables revenue is now surpassing their mist system revenue by a large margin, and that's recurring, higher margin revenue. Shows the customers who buy the mist systems are using them too. Youtube has some pretty great videos showing how the mist system works, and every review I've read has glowing reviews.

been accumulating 14-17 for a lonnnnnnnnnggggggggg time - seems ;like pay day is finally starting to come ... i plan to hold for a while more to. avg at 28

Janey are you in this one? Seems cheap for profitable growth.

Well, you called it DrZ

SEP Acquisition Corp.’s planned merger with SANUWAVE Health, Inc. has been cancelled as SANUWAVE decided to terminate the agreement. With the termination, all previous obligations have ceased, and neither party faces any liability, except for the terms that are designed to survive the termination of the agreement. This unexpected turn of events will likely interest stockholders and market watchers following the corporate strategies of both companies.

SEP Acquisition Corp.’s planned merger with SANUWAVE Health, Inc. has been cancelled as SANUWAVE decided to terminate the agreement. With the termination, all previous obligations have ceased, and neither party faces any liability, except for the terms that are designed to survive the termination of the agreement. This unexpected turn of events will likely interest stockholders and market watchers following the corporate strategies of both companies.

Please, stop trying to cheer me up

Why would any sober minded investor/individual, who has been with SNWV for some time, expect anything but debacle. Their business model is broken, decision making suspect, and in so long as KR is involved, it will remain so. SNWV is penny stock.

Based on discussions with The Nasdaq Stock Market LLC (“Nasdaq”), SEP Acquisition Corp., a Delaware corporation (the “Company”), and SANUWAVE Health, Inc., a Nevada corporation (“SANUWAVE”), determined that the combined company was unlikely to be able to meet Nasdaq listing requirements and withdrew its listing application in order to submit an application to the Cboe BZX Exchange, Inc. This application is currently under review.

On March 6, 2024, Sanuwave, Inc. entered into an exclusive license and option agreement (the “License and Option Agreement”) with a third party licensee (the “Licensee”) in connection with a portfolio of Sanuwave, Inc. patents related to the field of intravascular shockwave applications (the “Patents”). In exchange for a one-time payment of $2.5 million, Sanuwave, Inc. granted the Licensee an exclusive license to the Patents and an option to acquire the Patents for an additional one-time payment in the single-digit millions of dollars (the “License and Option Transaction”). If the Licensee does not exercise its option to acquire the Patents during a specified option period, the license terminates and all rights revert back to Sanuwave, Inc.

* SEP ACQUISITION CORP (SEPA) - PURSUANT TO AMENDMENT, "OUTSIDE DATE" UNDER MERGER AGREEMENT HAS BEEN EXTENDED TO APRIL 30, 2024

I am the only person in the world that has purchased the stock today. Yay me.

janey not wrong - rest of world not right

got over that hurdle ... should be full-on heading toward the close of the transaction ...

janey says: we will be over 3 for good by the end of the week

i've got some of each as well

Splitting my position between the two to play any extra upside one or the other may have in the end. Completely under the radar transaction and promising revenue stream for a well funded entity following the combination. Easy money to be had at these levels.

are you playing the SEPA side at all?

That would be a nice 5X or 6X from here

This is a 0.15 stock on the slightest hint of positive news. I’m loading at these levels now that we’ve bounced off the bottom. A big jump is coming given the consolidation in the 0.025 range

big day coming up tomorrow - shareholder vote on the SPAC

Sanuwave Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA)

EDEN PRAIRIE, MN, January 22, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced the Company is holding a special meeting of stockholders on February 21, 2024 at 10:00 a.m. CT (11:00 a.m. ET) to vote on the previously announced merger with SEP Acquisition Corp (“SEPA”).

Sanuwave announced on August 23, 2023 that the Company entered into an Agreement and Plan of Merger with Sweat Equity Partners and Mercury Life Sciences-affiliated SEPA. Upon closing, the combined company is expected to trade on the Nasdaq Capital Market under the symbol “SNWV”.

The Company has commenced mailing proxy materials to stockholders to vote on proposals related to the merger with SEPA. Stockholders of record at the close of business on January 10, 2023 will be entitled to vote at the special meeting.

The Company’s board of directors unanimously recommends that stockholders vote “FOR” the merger proposal.

“Speaking for the Company and its board of directors, we’re all extremely excited about this transaction and see it as the freeing move to put the company upon a sound financial footing, simplify the capital structure, and to move up to the Nasdaq Capital Markets, said Sanuwave CEO Morgan Frank. “This will allow us to focus on rapid, profitable growth and to garner an equity valuation that reflects the performance of our business. My deep thanks to the Sanuwave team and all those who have helped us get here.”

"A leading provider of next-generation FDA-approved wound care products."
"UltraMist revenues accounted for approximately 95% of the company’s total revenue."

I'm sorry, but after 5+ years in the wound care space two things remain clear.
1, Despite millions spent in the push of the DP product, and having that as sole #1 focus, the back burner (10+ year old techno) product is the only bullet in the gun.
2. Calling SNWV a leader of next-generation WC products is akin to calling the Big Mac nutritious.

EDEN PRAIRIE, MN, Jan. 10, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – SANUWAVE Health, Inc. (SNWV) (the "Company" or "SANUWAVE”) , a leading provider of next-generation FDA-approved wound care products, today announced that revenues for the fourth quarter of 2023 are expected to be in the range of $6.6 to $6.8 million, an increase of 20% to 24% over Q4 2022. Fiscal year 2023 revenues are expected to be in the range of $20.0 million to $20.2 million, an increase of 19% to 20% over the fiscal year ended 2022.

“Q4 2023 was a record quarter of revenue for SANUWAVE driven by strength in the UltraMist product line. Consumables and in particular system sales saw accelerating growth as production constraints were overcome,” said CEO Morgan Frank. “We’re extremely pleased to have shown this level of growth year on year up against what had previously been the best quarter in SANUWAVE history in Q4 2022 and look forward to carrying this success on into 2024. The Company plans to release its full Q4 and annual results in late March and we look forward to speaking with you then to give you a more complete update on our quarterly and yearly performance and our future plans and guidance.”

The preliminary revenue results described herein are based on management’s initial analysis of the fourth quarter ended December 31, 2023, and may be subject to adjustments based on the Company’s completion of its year-end financial close process.

· The transaction is expected to close in the fourth quarter of 2023, subject to the satisfaction of the agreed upon closing conditions.

Hmph - soon ... ?

DrZ? Still lurking? Nice way tp start year - musta been some heavy tax selling keeping it down.

somebody dum[ping this shit hard - SPAC called off?????????

Almost 1mm shares in a Green Day … whuuuuuut!!

lottsa dumpin goin on

5m share day

All good Q, Z.

Looks like a binary outcome here: SPAC happens, they get to NASDAQ and its rainbows and lucky charms OR spac doesnt happen and it goes down the shittter.

What are you betting on?

https://www.investopedia.com/ask/answers/011315/what-difference-between-authorized-shares-and-outstanding-shares.asp#

Authorized shares are the maximum number of shares a company is allowed to issue to investors as laid out in its articles of incorporation.

Outstanding shares are the actual shares issued or sold to investors from the available number of authorized shares.

Friday 8 AM EST conference call feels like they're trying to squeak out some bad Q3 numbers - at that rate just do it 5 PM PST on frday!

the smart money is already in at this level

doin' a little bottom feeding ... SPAC and uplist should happen in the next 60 days

There are approximately 3.0 Billion shares outstanding not including the $25.0 milliion to Morgan Stanley
So, at $.02/share the current market cap is $60.0 million.
You add in the $25.0 million of debt and that comes to $85.0 milllion
The valuation seems fair.....haven't done a deep dive on how much we (sanuwave will have after the merger. I'm assuming the spac sponsors will retain 20%
So, yeah...these numbers seem right

how can this possibly be true:

"Sanuwave is being valued at a total enterprise value of $125 million in the transaction and holders of Sanuwave common stock will upon consummation of the merger receive shares of SEPA Class A common stock in exchange for their existing holdings. "

When the co is valued at Market cap. Micro Cap ($19.34M) by the share price. Something is def fishy here.

Am i being naive ...

- douche bag CEO gone
- SPAC uplist to NASDAQ
- new board, new mgmt
- an articulable strategy (like it or not like it)

Assuming SPAC has done it's homework, it looks like there is value here.

New presentation filed with the SEC yesterday. More info to come with the S4 as well.

what is going to happen with this coming acquisition?

I see where 3 of SNWV's primary and former RMs filed joint legal action against them in July. Noticed the new group also made zero mention of the main focus and driving force behind SNWV. Have they finally walked away from that non-producing DP? Are they going to rely on tired worn technology as the driver? Technology that they have admitted to not having an inventory of since 10/21.

dr z smith....so whats your opinion on the latest news...
the merger...
looking forward to what you have to say,

best to you

You mean 2.0 BILLION shares. You didn't account for the warrants last time either.

All that and 1,000,000,000 shares OS

Since approval, DP had never had legitimate momentum in the wound care space. The financials/sales validate that fact. Without competitive reimbursement and a solid business plan (which has never been present), it's impossible to obtain traction and be competitive. Moreover, there are multiple like players in this tech space with much better leadership, direction, and pricing. On the flip, Mist is old technology, breaks down easily, and no company has produced a new unit since Alliqua.

The bottom line is the low single is where SNWV stock will live until sold off.

And derma pace all but shelved.

95% revenues for foreseeable future from Mist